Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Muscarinic antagonists microinjected into the subthalamic nucleus decrease muscular rigidity in reserpinized rats

S Hernández-López1, G Flores, M G Rosales

  • 1Departamento de Fisiología, Biofísica y Neurociencias, CINVESTAV-IPN, México D.F., Mexico.

Neuroscience Letters
|August 9, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clarifying the N,Z=14 Shells near the Drip Lines from the Spectroscopy of ^{22}Si and ^{21}Al.

Physical review letters·2026
Same author

Fast and accurate visual acuity prediction based on optical aberrations and machine learning.

Scientific reports·2025
Same author

Outcomes of Percutaneous Nephrolithotomy in Kidney Transplant Recipients: Results from a Multicenter Study by the Spanish Urology Association's Renal Transplant Group.

World journal of urology·2025
Same author

Genomic profiling unlocks new treatment opportunities for ampullary carcinoma.

ESMO open·2025
Same author

PACAP induces increased excitability in D1- and D2-expressing nucleus accumbens medium spiny neurons.

Brain research bulletin·2025
Same author

Opposing effects of nicotine on hypothalamic arcuate nucleus POMC and NPY neurons.

Progress in neurobiology·2024
Same journal

Dynorphinergic neuroadaptations in the islands of Calleja: implications for alcohol use disorder.

Neuroscience letters·2026
Same journal

Differential vulnerability of cochlear nuclei to Lmx1 deficiency: abnormal patterning and implications for auditory circuitry.

Neuroscience letters·2026
Same journal

Role of nNOS/sGC pathway in the insular cortex in control of cardiovascular, autonomic and corticosterone responses to restraint stress in rats.

Neuroscience letters·2026
Same journal

Jak1 inhibition reduces acute allodynia induced by specific upstream cytokines in rats: implications for the onset of Jak1 pain modulation.

Neuroscience letters·2026
Same journal

Glucocorticoids-induced depressive-like behaviors in mice: oral ingestion of corticosterone or hydrocortisone - A comparative study.

Neuroscience letters·2026
Same journal

Data-driven clustering of prefrontal activation identifies functional phenotypes under prioritized dual-task walking conditions in Parkinson's disease.

Neuroscience letters·2026
See all related articles

Anticholinergic agents targeting the M3 muscarinic receptor in the subthalamic nucleus effectively reduced muscle rigidity in a rat model of Parkinson's disease. This highlights the role of cholinergic signaling in this condition.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Neurology

Background:

  • Parkinson's disease is characterized by motor symptoms like muscular rigidity.
  • The subthalamic nucleus plays a crucial role in motor control.
  • Cholinergic pathways are implicated in the pathophysiology of Parkinsonism.

Purpose of the Study:

  • To investigate the role of muscarinic acetylcholine receptors in the subthalamic nucleus in reserpine-induced muscular rigidity in rats.
  • To evaluate the efficacy of selective muscarinic antagonists in ameliorating Parkinsonian-like symptoms.

Main Methods:

  • Rats were administered reserpine to induce muscular rigidity, measured via electromyography of the gastrocnemius-soleus muscle.
  • Anticholinergic agents, specifically M1 (pirenzepine) and M3 (4-DAMP) antagonists, were microinjected into the subthalamic nucleus.

Related Experiment Videos

  • The effect of M2 antagonist AFDX-116 was also assessed.

    • Main Results:

    • Reserpine administration significantly increased electromyographical activity, indicating muscular rigidity.
    • Microinjection of M3 antagonist 4-DAMP and M1 antagonist pirenzepine markedly reduced reserpine-induced rigidity.
    • The M2 antagonist AFDX-116 showed no significant effect on muscular rigidity.

    Conclusions:

    • A heightened cholinergic tone within the subthalamic nucleus is associated with reserpine-induced muscular rigidity.
    • M3 muscarinic receptor antagonism is more effective than M1 antagonism in alleviating muscular rigidity in this Parkinson's disease model.
    • Targeting M3 receptors in the subthalamic nucleus represents a potential therapeutic strategy for Parkinsonian rigidity.